Indoco Counts On Indian Market Bouncing Back
Company Plans To Ramp Up Its Partnership With Teva By FY22
Indoco’s domestic performance picks up pace as the Indian pharma market sees a “bounce back” after a long COVID-induced slump. The Indian company continues to perform well internationally and grow overall.
